Sorrento Therapeutics Inc. (SRNE): Wildcat Capital Management Growing Impatient With Lack of Disclosure, Repeats Demands

Page 14 of 14

Page 14 of 14 – SEC Filing

(4) Incorporated
herein by reference to Letter to the Board of Directors of the Issuer, dated May 5, 2016, which was previously filed with the SEC
as Exhibit 4 to Amendment No. 2 to Schedule 13D filed by Wildcat, WLA, IQCM, IQME, IQDA, BFLP, Leonard A. Potter and James Velissaris,
on May 6, 2016.

(5) Incorporated
herein by reference to Letter to the Board of Directors of the Issuer, dated May 10, 2016, which was previously filed with the
SEC as Exhibit 5 to Amendment No. 3 to Schedule 13D filed by Wildcat, WLA, IQCM, IQME, IQDA, BFLP, Leonard A. Potter and James
Velissaris, on May 11, 2016.

(6) Incorporated
herein by reference to Verified Derivative Complaint filed in the Court of Chancery of the State of Delaware on May 13, 2016, which
was previously filed with the SEC as Exhibit 6 to Amendment No. 4 to Schedule 13D filed by Wildcat, WLA, IQCM, IQME, IQDA, BFLP,
Leonard A. Potter and James Velissaris, on May 16, 2016.

(7) Incorporated
herein by reference to Plaintiff’s Motion for Temporary Restraining Order filed in the Court of Chancery of the State of Delaware
on May 13, 2016, which was previously filed with the SEC as Exhibit 7 to Amendment No. 4 to Schedule 13D filed by Wildcat, WLA,
IQCM, IQME, IQDA, BFLP, Leonard A. Potter and James Velissaris, on May 16, 2016.

(8) Incorporated
herein by reference to Plaintiff’s Brief in Support of Motion for Temporary Restraining Order, to Expedite the Proceedings,
and to Schedule a Preliminary Injunction Hearing, filed in the Court of Chancery of the State of Delaware on May 13, 2016, which
was previously filed with the SEC as Exhibit 8 to Amendment No. 4 to Schedule 13D filed by Wildcat, WLA, IQCM, IQME, IQDA, BFLP,
Leonard A. Potter and James Velissaris, on May 16, 2016.

Page 14 of 14 Pages

Follow Sorrento Therapeutics Inc. (NASDAQ:SRNEQ)

Page 14 of 14